Matches in Nanopublications for { ?s ?p "[Elevated pretreatment levels of hTERT were identified in 80.2% of squamous cell carcinoma and 73.8% of adenocarcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP600752.RAfdjOrGIav8tGHY0kQuMUagWUPEoAtSw_qdmdjOz0gdM130_assertion description "[Elevated pretreatment levels of hTERT were identified in 80.2% of squamous cell carcinoma and 73.8% of adenocarcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600752.RAfdjOrGIav8tGHY0kQuMUagWUPEoAtSw_qdmdjOz0gdM130_provenance.
- NP882274.RAldS5zMEl1rWFoWOCKZD7YGEFm0RpQWq5I7ozg3pff_k130_assertion description "[Elevated pretreatment levels of hTERT were identified in 80.2% of squamous cell carcinoma and 73.8% of adenocarcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882274.RAldS5zMEl1rWFoWOCKZD7YGEFm0RpQWq5I7ozg3pff_k130_provenance.
- NP429957.RAIA7OgbZkO-andP_bw0yP6dfBDgjPsg6L-pgiQU44c6Q130_assertion description "[Elevated pretreatment levels of hTERT were identified in 80.2% of squamous cell carcinoma and 73.8% of adenocarcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429957.RAIA7OgbZkO-andP_bw0yP6dfBDgjPsg6L-pgiQU44c6Q130_provenance.